ISPOR Europe 2026
Panel Patient-Centered Evidence track
Patient-Reported Outcomes in Federated Real-World Data: Infrastructure Ready, Evidence Fit for HTA?
Mon, Nov 9, 2026 · 10:30–11:30 AM CET Hall E2, Level 0, Austria Center Vienna
About this session
ISSUE Health Technology Assessment (HTA) bodies, regulators, and healthcare decision-makers increasingly require high-quality longitudinal patient-reported outcome (PRO) evidence to evaluate real-world treatment effectiveness and safety, evidence that trial environments alone cannot provide.
Speakers
-
UMIT TIROL - University for Health Sciences and Technology; Harvard Chan School of Public Health
Moderator
